Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin

Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin

US Patent 7622470 · Granted Nov 24, 2009

Estimated economic value: $36,961,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Histone acetyltransferase activators and compositions and uses thereof2025
Implantable particles and related methods2024
Combination therapy of lymphoma2023
Histone acetyltransferase activators and compositions and uses thereof2022
Histone acetyltransferase activators and uses thereof2021
Compounds for reducing c-Myc in c-Myc overexpressing cancers background2021
Histone acetyltransferase activators and compositions and uses thereof2020
N-quinolin-benzensulfonamides and related compounds for the treatment of cancer,2018
Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin2012
Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin2012
Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaa2012
Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaa2012